Toxic erythema

L12_ERTYTH_TOXIC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L53.0 Hospital discharge: ICD-9 — 6950A\|6951D Hospital discharge: ICD-8 — 69500 Cause of death: ICD-10 — L53.0 Cause of death: ICD-9 — 6950A\|6951D Cause of death: ICD-8 — 69500 2 out of 7 registries used, show all original rules.	68
4. Check minimum number of events None	68
5. Include endpoints None	68
6. Filter based on genotype QC (FinnGen only)	68

Control definitions (FinnGen only)

Control exclude: L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L53
Name in latin: Erythema toxicum

NAME	L12_ERTYTH_TOXIC
CONTROL_EXCLUDE	L12_URTICARIAERYTHEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L530
HD_ICD_9	6950A\|6951D
HD_ICD_8	69500
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L530
COD_ICD_9	6950A\|6951D
COD_ICD_8	69500
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Toxic erythema based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	643	346	293
Only index persons	480	272	208
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	41.77	45.18	37.64
Only index persons	35.89	39.71	30.89

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	68	47	21
Unadjusted period prevalence (%)	0.01	0.02	0.01
Median age at first event (years)	38.96	39.83	37.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
63: Matched controls
631

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L53.0

ICD-10 Finland

Toxic erythema

+∞

44.0

6951D

ICD-9 Finland

Erythematous conditions, Erythema multiforme[ERYTHEMA FIXUM]

+∞

14.1

69500

ICD-8 Finland

Erythematous condition, Toxic erythema

+∞

8.5

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026008) Bacteria identified in Urine by Culture

152

2.58

3.46

3.2

2.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

149

2.49

3.19

2.7

2.1

132.6

137.9

u/l

0.06

140

(3013139) Helicobacter pylori Ag [Presence] in Stool

3.87

3.18

2.0

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

5.86

2.60

1.0

1.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

222

2.19

2.54

2.4

2.3

69.6

76.4

nmol/l

1.17

200

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

5.36

2.46

1.0

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

103

2.33

2.37

1.7

1.6

0.6

0.9

mg/l

0.77

(3044889) 12 lead EKG panel

354

2.21

2.28

3.0

3.5

—

(3000494) Fungus identified in Specimen by Culture

2.58

2.26

1.1

1.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

163

2.09

2.15

3.7

3.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

5.30

2.11

1.2

1.0

—

(40768443) Skin Pathology biopsy report

3.59

2.02

1.4

1.2

—

(3045414) Leukocytes [Presence] in Urine

4.00

1.98

1.3

1.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2.69

1.85

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.25

1.81

1.7

2.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

403

2.06

1.79

4.0

4.2

9.8

11.1

mm/h

0.36

374

(3022313) Gas panel - Capillary blood

3.36

1.70

1.8

4.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

3.76

1.64

1.2

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3.03

1.54

2.0

2.1

1.0

1.6

—

(40761535) Cells panel - Urine sediment

2.50

1.50

4.0

3.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2.89

1.47

2.0

3.6

24.6

24.8

mmol/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

538

2.30

1.42

17.4

13.3

22.2

20.1

mg/l

0.23

412

(3009508) Creatinine [Moles/volume] in Urine

141

1.83

1.40

2.6

2.8

6.8

7.6

mmol/l

0.24

110

(3016879) Cocaine [Presence] in Urine

3.09

1.38

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

3.09

1.38

1.0

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

3.09

1.38

2.0

4.3

23.9

24.8

mmol/l

—

(42870588) Differential panel, method unspecified - Blood

168

1.77

1.36

3.9

5.4

—

(3028300) Cannabinoids [Presence] in Urine

2.76

1.24

1.2

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

2.76

1.24

1.2

1.3

—

(3027008) Opiates [Presence] in Urine

2.76

1.24

1.2

1.3

—

(3023368) Bacteria identified in Blood by Culture

113

1.81

1.21

3.5

5.0

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

275

1.66

1.21

4.1

6.5

10.9

11.1

umol/l

0.04

263

(3019309) Folate [Moles/volume] in Red Blood Cells

1.88

1.20

2.1

1.8

1650.3

1306.2

nmol/l

—

(3030467) Casts [#/volume] in Urine by Automated count

131

1.75

1.17

2.9

2.7

0.0

0.5

e6/l

2.44

(3027944) Amphetamines [Presence] in Urine

2.61

1.17

1.2

1.3

—

(3000492) Spirometry study

2.13

1.16

1.3

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

258

1.64

1.16

5.8

5.1

0.0

estimate

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1.85

1.04

2.3

2.5

0.2

0.9

e6/l

—

(3019225) pH of Specimen

1.96

1.03

3.9

5.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.96

0.98

1.5

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.96

0.98

1.4

2.0

—

(3009261) Glucose [Presence] in Urine by Test strip

266

1.56

0.97

4.6

3.8

0.0

estimate

—

(3022621) pH of Urine by Test strip

1.99

0.97

3.4

2.0

—

(3012544) pH of Venous blood

2.02

0.92

2.8

3.9

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1.97

0.91

1.6

2.2

9.4

9.9

g/l

—

(3032080) INR in Blood by Coagulation assay

194

1.55

0.90

7.3

8.4

1.2

inr

0.04

(4010399)

1.93

0.89

1.9

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

178

1.54

0.85

2.6

3.5

2.4

mmol/l

0.00

153

(3015736) pH of Urine

206

1.52

0.84

4.0

3.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.90

0.81

1.7

1.5

—

(36304419) Bacteria [Presence] in Urine

135

1.57

0.80

2.9

2.5

—

(3018095) Leukocytes [#/volume] in Urine

172

1.51

0.78

3.4

3.7

82.9

79.6

e6/l

0.02

129

(3004119) Hemoglobin [Mass/volume] in Venous blood

2.26

0.78

2.4

4.1

118.6

127.8

g/l

—

(3037467) Urinalysis macro (dipstick) panel - Urine

355

1.48

0.77

5.5

3.9

—

(40768797) Stomach Pathology biopsy report

1.74

0.77

1.1

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.74

0.77

5.1

7.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

503

1.64

0.77

12.4

12.3

82.5

81.6

ml/min/173m2

0.10

392

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.67

0.75

2.4

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

120

1.56

0.74

4.2

3.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

203

1.45

0.71

2.2

1.9

115.2

101.9

pmol/l

0.43

(3035350) Ketones [Presence] in Urine by Test strip

260

1.44

0.71

4.6

3.7

0.0

estimate

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.64

0.63

2.3

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

556

1.67

0.62

18.5

15.4

72.5

74.7

umol/l

0.35

556

(3020682) Albumin/Creatinine [Ratio] in Urine

144

1.44

0.59

3.6

3.7

40.6

2.6

mg/mmol

0.99

(3013512) EKG study

154

1.42

0.57

5.2

3.1

—

(40768804) Tissue Pathology biopsy report

211

1.38

0.55

2.1

2.2

—

(3025941) Bacteria identified in Stool by Culture

1.59

0.54

1.3

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

107

0.61

0.54

1.3

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

514

0.72

0.52

4.3

3.8

1.4

1.3

mmol/l

0.34

470

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

118

0.64

0.51

1.8

2.1

—

(40761511) CBC panel - Blood by Automated count

560

1.61

0.51

16.6

12.1

—

(3002582) Erythrocytes [#/volume] in Urine

150

1.37

0.47

3.1

2.9

18.4

429.7

e6/l

0.51

122

(3012516) Albumin [Mass/volume] in Urine

133

1.37

0.44

2.8

3.0

125.4

16.4

mg/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

124

1.38

0.44

2.3

5.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.42

0.43

2.2

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.42

0.0

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

107

1.39

0.41

1.8

1.6

2.5

2.9

g/l

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

191

1.31

0.41

5.9

3.3

62.5

23.7

ng/l

0.51

122

(3007853) Bacteria identified in Skin by Aerobe culture

1.42

0.40

1.6

1.5

—

(3000991) Gas panel - Venous blood

1.46

0.40

2.6

9.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.46

0.40

1.2

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

409

1.30

0.40

6.0

4.1

14.9

14.6

pmol/l

0.43

371

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

526

0.76

0.39

4.8

4.3

5.6

5.8

mmol/l

1.91

485

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

360

1.27

0.37

3.3

3.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.43

0.36

1.0

1.7

—

(21494755) Public health laboratory ask at order entry panel

1.39

0.32

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

149

1.28

0.32

5.9

3.8

0.0

estimate

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

500

1.27

0.29

6.7

4.7

1.7

1.8

mu/l

0.29

451

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

490

1.26

0.28

6.3

5.1

39.1

39.5

mmol/mol

0.11

462

(1761868) Lipid panel - Serum or Plasma

200

0.80

0.27

1.9

2.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

105

1.29

0.27

1.5

1.2

32.4

3.6

u/ml

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

124

1.27

0.27

1.3

1.2

0.7

u/ml

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.21

0.0

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.21

0.0

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.25

0.20

2.5

2.1

327.2

407.8

nmol/l

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.20

0.0

2.6

—

16.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.20

0.0

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.20

0.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.22

0.20

1.5

1.4

—

(3002256) Pathology report gross observation

1.21

0.19

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

101

1.23

0.18

1.4

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

490

1.16

0.15

16.9

13.4

37.3

40.4

0.92

376

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

210

1.14

0.14

5.4

3.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

533

1.17

0.13

4.3

4.7

4.8

mmol/l

0.12

496

(3003694) ABO and Rh group [Type] in Blood

134

1.15

0.12

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

536

1.14

0.09

4.4

4.8

2.9

2.8

mmol/l

0.21

494

(3042936) Bacteria identified in Isolate by Culture

0.84

0.08

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.04

0.07

1.6

—

(40758558) Short blood count panel - Blood

138

1.11

0.07

5.5

6.8

—

(3044640) Blood type and Crossmatch panel - Blood

166

0.95

0.00

1.9

2.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

244

1.04

0.00

4.6

4.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

147

1.03

0.00

4.6

3.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

531

0.99

0.00

4.3

1.5

mmol/l

0.01

490

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

0.98

0.00

4.6

3.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.0

5.5

—

4.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

3.9

—

177.9

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

0.0

1.2

—

18.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

0.0

2.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.0

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.0

1.2

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

15.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

2.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

13.2

—

(4062490)

0.00

0.0

1.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.92

0.00

1.7

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

0.0

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

2.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

0.0

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.0

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.6

—

(3045788) Cell count panel - Pleural fluid

0.00

-0.00

0.0

1.2

—

(4281824)

0.00

-0.00

0.0

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

-0.00

0.0

4.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

4.0

—

2.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

29.8

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.4

—

1976.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.0

—

(40768806) Pleura Pathology biopsy report

0.00

-0.00

0.0

1.8

—

(1175426) CD3 cells/100 lymphocytes in Blood

0.00

-0.00

0.0

3.0

—

84.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3042631) Mycobacterium sp identified in Specimen

0.00

-0.00

0.0

5.6

—

(3017704) Immunofixation for Urine

0.00

-0.00

0.0

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

-0.00

0.0

13.8

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.0

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.2

—

31.6

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.4

—

201.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ERTYTH_TOXIC and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_ERTYTH_TOXIC.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_ERTYTH_TOXIC – Toxic erythema

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Toxic erythema

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints